Research Projects

INTEGRIS Grove General was selected to be part of the TIMI-19 Study because of its excellent Emergency Medical Services and Emergency Room staff.  This meant that the Grove EMS would not only have an up-to-date communication system, it would also be one of the first emergency medical services in the country  to use thrombolytics (anti-clot medicine used to treat heart attack victims) as part of their advanced life-support pre-hospital care. Only 12 facilities in the U.S. were  selected to participate in the TIMI-19 study, and INTEGRIS Grove and Grove EMS together were one of the 12.

TIMI stands for "Thrombolysis in Myocardial Infarction" (heart attack). The 19 indicates that this was the 19th study in the use of clot-dissolving drugs in the treatment  of heart attacks. The drug used in this study, Retavase, saves an additional ten lives per thousand suffering heart attacks if the drug is administered in a timely  manner to eligible heart attack victims.

    Send Page to a Friend | Print Page | Add Page to Favorites
Site Index | Privacy Policy | Disclaimer | Release of Information | Contact Us

All health care services are provided through affiliates and/or
subsidiaries of INTEGRIS Health, Inc.


November 21
IBMC Cancer Screening - Females
KISS: Keys in Smple Success !
CAR SEAT SAFETY CHECKS
November 24
HeartSaver CPR at Pacer Fitness Center
November 25
Ask a Pharmacist
December 01
Plans Change- You Change-Brookline
more...
INTEGRIS Health: Our Commitment to Diversity
Visit our Web Nursery
 
 
INTEGRIS Grove General Hospital
1310 S. Main
Grove, OK 74344
(918) 786-2243

INTEGRIS HealthLine
(888) 951-2277